Navigation Links
Cord Blood America CEO Matthew Schissler Interviewed by BIONOVA, Greece's Leading Biotech Magazine
Date:2/12/2008

SANTA MONICA, Calif., Feb. 12 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced that CEO Matthew L. Schissler was interviewed by the leading biotechnology publication in Greece, where Cord Blood America established a partnership in 2006 named a.bourkas Co., United.

"Stem cells are used today in the treatment of leukemia, breast cancer, lymphoma, Hodgkin's Disease, aplastic anemia, sickle cell anemia, various other cancers, blood diseases, hereditary and genetic conditions and immune system disorders," Mr. Schissler said in the interview. "As stem cell transplants become routine, they may be used to fight many other cancers, viruses and genetic disorders."

"Umbilical cord stem cells are used to repopulate one's immune system. An example would be a leukemia patient who undergoes radiation therapy. The stem cells from the umbilical cord repopulate the patient's immune system with healthy cells to keep the body strong and to help fight other diseases," Cord Blood America's CEO said.

Mr. Schissler further explained that, "umbilical cord stem cells are a perfect match for the baby, but because of close genetic ties, there is a good chance they will match for immediate family members as well. They also may be a very good match for a sibling. Umbilical cord stem cells are the best because they have hematapoletic traits, meaning they repopulate the immune system and have regenerative traits meaning they can regenerate tissue."

Andreas Bourkas, Director and Manager of a.bourkas Co., United, said saving the umbilical cord at birth is starting to be a popular choice. "Greek's have very strong family ties and this is exactly the right step for a fam
'/>"/>

SOURCE Cord Blood America, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. CORD:USE Cord Blood Bank Announces the Addition of Dr. John Wagner, a Pioneer in the Use of Umbilical Cord Blood Stem Cells, to Its Scientific Advisory Board
2. National Association of Emergency Medical Technicians (NAEMT) Supports Prehospital Screening for Carbon Monoxide in the Blood
3. Dr. Charles A. Sims of California Cryobanks Family Cord Blood Services Named to National Stem Cell Advisory Council
4. Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure
5. Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV-I/HTLV-II
6. GeneNews initiates patient sample accrual for validation studies of colon cancer blood test
7. A&G Pharmaceutical Receives $870,000 Grant from Avon Foundation to Advance Innovative Blood Diagnostic Test for Early Detection of Breast Cancer
8. 49th Annual Meeting of the American Society of Hematology Will Feature the Latest Research in Blood Diseases
9. FDA Approves Diovan(R) for Treatment of High Blood Pressure in Children
10. Cord Blood America Announces Financing
11. AspenBio Pharma Pursues FDA 510(k) Application Pathway for Appendicitis Blood Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , July 1, 2015   Decision ... frequently cited advantages of Otezla are its oral ... profile, as reported by surveyed rheumatologists. Otezla was ... for the treatment of active psoriatic arthritis in ... current standard of care includes conventional oral treatments ...
(Date:7/1/2015)... Bermuda , July 1, 2015  Axovant ... company focused on the treatment of dementia, today ... briefing on July 22 at 5:45 p.m. EDT ... the Alzheimer,s Association International Conference 2015 (AAIC). ... remarks: , Dr. Lawrence Friedhoff ...
(Date:7/1/2015)... ... 01, 2015 , ... Apex Therapeutics announced today that company CEO, David Broecker ... , The presentation took place on Tuesday, June 16 and provided an update ... APX3330 for the treatment of pancreatic cancer. A copy of the company overview ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... to take part in the first half of “Integrative Biotechnology,” an applied biotechnology ... established in summer 2014, this course combines students from both universities and is ...
Breaking Biology Technology:Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2Rivier University and Beijing City University Academic and Cultural Exchanges Begin 2
... Net Income & EBITDA (as adjusted) Increases of 21% ... ... Mac-Gray Corporation,(NYSE: TUC ), the nation,s premier provider of laundry ... first quarter ended March 31, 2008., Mac-Gray reported record first-quarter revenue ...
... Dana-Farber and Colorado Treating Patients with ENMD-2076, ... Inc. (Nasdaq:,ENMD), a clinical-stage pharmaceutical company developing ... diseases, today announced that,Dana-Farber Cancer Institute has ... conducting a Phase 1 study of ENMD-2076 ...
... Wash., May 8 BioLife Solutions Inc.,(OTC Bulletin ... proprietary,hypothermic storage and cryopreservation media products for cells, ... for CryoStor,cryopreservation media has been accepted by the ... Chairman and Chief Executive Mike Rice commented: "We ...
Cached Biology Technology:Mac-Gray Corporation Announces First-Quarter 2008 Financial Results 2Mac-Gray Corporation Announces First-Quarter 2008 Financial Results 3Mac-Gray Corporation Announces First-Quarter 2008 Financial Results 4Mac-Gray Corporation Announces First-Quarter 2008 Financial Results 5Mac-Gray Corporation Announces First-Quarter 2008 Financial Results 6Mac-Gray Corporation Announces First-Quarter 2008 Financial Results 7Mac-Gray Corporation Announces First-Quarter 2008 Financial Results 8Mac-Gray Corporation Announces First-Quarter 2008 Financial Results 9Mac-Gray Corporation Announces First-Quarter 2008 Financial Results 10Mac-Gray Corporation Announces First-Quarter 2008 Financial Results 11Mac-Gray Corporation Announces First-Quarter 2008 Financial Results 12Mac-Gray Corporation Announces First-Quarter 2008 Financial Results 13Mac-Gray Corporation Announces First-Quarter 2008 Financial Results 14Dana-Farber Cancer Institute Commences Phase 1 Trial With EntreMed's Selective Kinase Inhibitor 2Dana-Farber Cancer Institute Commences Phase 1 Trial With EntreMed's Selective Kinase Inhibitor 3BioLife Solutions Announces FDA Master File Acceptance for CryoStor(TM) Pre-formulated Cryopreservation Media 2BioLife Solutions Announces FDA Master File Acceptance for CryoStor(TM) Pre-formulated Cryopreservation Media 3
(Date:6/30/2015)... , June 30, 2015 Genisphere ... as CEO to help further develop Genisphere,s therapeutics capabilities ... partnering experience, having spent much of the last 25 ... Amgen, Baxter Bioscience, and Johnson & Johnson. Tom started ... Technology and Biotech Corporate Finance. He graduated from Dartmouth ...
(Date:6/25/2015)... June 25, 2015  TAKE Solutions Ltd., a global ... the United States Patent and Trademark Office (USPTO) for ... leverages TAKE Solutions, Clinical Accelerators to reduce the time ... compared to standardization without the accelerators), thus reducing time ... At the heart of the patented Clinical ...
(Date:6/24/2015)... 2015 Biometry authentication provider KeyLemon today ... solution one face in. Logo ... face in, entering the expanding biometric authentication market ... biometric answer to the password problem. With advanced ... with KeyLemon, one face in allows users to ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3TAKE Solutions Awarded Patent By USPTO 2KeyLemon Announces Partnership With Biometric Password Solution onefacein 2
... In the largest prospective study to date of children ... (ASD) compared to children without ASD, researchers found two ... the children with ASD. Published in the journal ... development, children who display early signs of ASD show ...
... A group of researchers in Israel, the United States and ... of "regenerative medicine," outlining for the first time connections ... and facial muscles. Some of these problems are surprisingly ... congenital heart defect. This basic research will provide a road ...
... Biking, running and walking are all good for you. But the ... from other joint problems or injuries. What to do? Just add ... found that people who used an immersible ergocycle basically an ... workout to using a typical stationary bike. "If you can,t ...
Cached Biology News:Distinct developmental patterns identified in children with autism during their first 3 years 2Distinct developmental patterns identified in children with autism during their first 3 years 3Researchers identify genetic basis of cardiac, craniofacial birth defects 2Researchers identify genetic basis of cardiac, craniofacial birth defects 3Everyone in the pool! Water workouts just as good as on land 2
...
...
... XL provides RS232/Serial data collection and automation ... Complete instrument integration with Microsoft Excel ... balances, pH meters, titrators, density meters, force ... and serial instruments can be added and ...
... the family of calcium binding proteins such as ... of an alpha and beta chain whereas S100B ... protein is also expressed in the antigen presenting ... and interdigitating reticulum cells in the paracortex of ...
Biology Products: